Glenmark Pharma gets ANDA approval for Triamcinolone Acetonide Cream USP

Glenmark Pharmaceuticals Inc USA has been granted final approval by the USFDA for Triamcinolone Acetonide Cream USP, 0.1 percent the generic version of Kenalog Cream, 0.1 percent of Delcor Asset Corporation.

August 08, 2016 / 09:11 IST

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated August 08, 2016 titled "Glenmark Pharmaceuticals receives ANDA approval for Triamcinolone Acetonide Cream USP, 0.1%".Source : BSE

Read all announcements in Glenmark

first published: Aug 8, 2016 09:11 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Glenmark Pharma gets ANDA approval for Triamcinolone Acetonide Cream USP

Glenmark Pharmaceuticals Inc USA has been granted final approval by the USFDA for Triamcinolone Acetonide Cream USP, 0.1 percent the generic version of Kenalog Cream, 0.1 percent of Delcor Asset Corporation.

GP08